AACR Presentation

(Chicago, Illinois) — April 9, 2024 — ExoMira Medicine is proud to announce that Scientific Co-Founder Huiping Liu, MD, PhD, presented cutting-edge research at the American Association for Cancer Research (AACR) 2024 Annual Meeting during the Major Symposium Session SY34: Cancer Dormancy: From Basic Biology to Clinical Reality, chaired by Dr. Mikala Egeblad.

Dr. Liu’s presentation, titled “Plasticity, dormancy, and glycosylation of circulating tumor cell (CTC) clusters in response to therapy,” explored emerging insights into the biological behavior of CTC clusters under therapeutic stress—an area directly relevant to ExoMira’s mission of targeting treatment-resistant cancer cell states. Her work highlights the role of cellular plasticity and post-translational modifications, such as glycosylation, in regulating tumor dormancy and metastatic reactivation.

ExoMira congratulates Dr. Liu on this prestigious AACR symposium selection and her continued leadership in advancing the science behind next-generation cancer therapeutics.